Xencor (XNCR) Change in Intangibles (2013 - 2024)
Xencor (XNCR) reported Change in Intangibles of $1.0 million for Q4 2024, up 40.36% year-over-year from $726000.0 in Q1 2024, and up 20.31% quarter-over-quarter from $847000.0 in Q3 2024.
Xencor (XNCR) Change in Intangibles (2013 - 2024) Analysis & Trends
Xencor (XNCR) has 12 years of Change in Intangibles data on file, last reported at $1.0 million in Q4 2024.
- Change in Intangibles for Q4 2024 came in at $1.0 million, up 40.36% year-over-year; the trailing twelve-month figure through Sep 2025 was $1.0 million (down 67.36% YoY), and the FY2024 annual result was $3.4 million, up 21.83% from the prior year.
- Change in Intangibles advanced to $1.0 million in Q4 2024 per XNCR's latest filing, from $847000.0 in the prior quarter.
- Over five years, Change in Intangibles peaked at $2.3 million in Q2 2022 and troughed at $72000.0 in Q1 2021.
- A 5-year average of $851950.0 and a median of $876500.0 in 2022 frame the typical range for Change in Intangibles.
- The sharpest annual moves came in 2021 and 2022: Change in Intangibles plunged 86.62% in 2021, then soared 1158.33% in 2022.
- A 5-year view of Change in Intangibles shows it stood at $1.1 million in 2020, then slumped by 69.24% to $334000.0 in 2021, then jumped by 179.34% to $933000.0 in 2022, then retreated by 22.19% to $726000.0 in 2023, then jumped by 40.36% to $1.0 million in 2024.
- Business Quant data shows XNCR's Change in Intangibles at $1.0 million in Q4 2024, $847000.0 in Q3 2024, and $620000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.02 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | 847,000.00 |
| Sep 30, 2024 | 847,000.00 |
| Jun 30, 2024 | 620,000.00 |
| Jun 30, 2024 | 620,000.00 |
| Mar 31, 2024 | 929,000.00 |
| Mar 31, 2024 | 929,000.00 |
| Dec 31, 2023 | 726,000.00 |
| Dec 31, 2023 | 726,000.00 |
| Sep 30, 2023 | 587,000.00 |
| Sep 30, 2023 | 587,000.00 |
| Jun 30, 2023 | 1.08 Mn |
| Jun 30, 2023 | 1.08 Mn |
| Mar 31, 2023 | 407,000.00 |
| Mar 31, 2023 | 407,000.00 |
| Dec 31, 2022 | 933,000.00 |
| Dec 31, 2022 | 933,000.00 |
| Sep 30, 2022 | 780,000.00 |
| Sep 30, 2022 | 780,000.00 |